Devices, digital health, and the technology changing how care is delivered.
Multiple factors could get in the way of confirming a new commissioner before the midterm elections, experts said, leaving the agency’s long-term initiatives in limbo.
Priority Health partnered with Color Health and Grail to offer self-funded employers virtual cancer navigation, support and multi-cancer early detection beginning in 2027. The post Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail appeared first on MedCity News .
Amgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s strategic objectives, Fierce has learned.
An analyst said Saccaro’s decision was “surprising,” adding that investors were not calling for his departure.
We’re about to enter a world beyond just talking to a chat tool about your health. AI tools are on the precipice of being able to take action on their advice. The post AI Will Reshape the Patient Experience appeared first on MedCity News .
The question is no longer whether healthcare innovation is accelerating. The question is where investors gain access to generate the strongest returns. The post Healthcare’s Next Source of Alpha Is Moving Upstream appeared first on MedCity News .
Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory submissions.
Scribe Therapeutics’ IPO will support a pipeline led by a genetic medicine that represses expression of its target gene without making permanent changes. Common chronic cardiometabolic conditions are Scribe’s initial focus as the biotech works to bring genetic medicines beyond rare diseases. The post CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO appeared first on MedCity News .
Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once tipped as a potential blockbuster “would not represent a meaningful improvement” to existing treatments.
Unlike past healthcare tech waves sold on cost savings, AI is proving it can generate new revenue — with returns as high as 100x, according to a panel of investors at MedCity News’ Bullseye event. The post Healthcare Investors Are Rewriting the ROI Playbook from Cost-Cutting to Cash Flow appeared first on MedCity News .
In vivo gene editing outfit Scribe Therapeutics has priced its IPO at $128.7 million, surpassing the $96 million goal set out earlier this week.
SCAN Health Plan CEO Sachin Jain and Ascendiun CEO Paul Markovich argued that healthcare leaders share responsibility for the industry’s shortcomings and called for greater accountability and systemic reform. The post Who Broke the Healthcare System? appeared first on MedCity News .
Selected devices will be exempt from certain premarket requirements while manufacturers collect real-world data through Medicare.
AI-focused Formation Bio has found a new chief scientist with extensive experience in biotech, Big Pharma and academia. Michael Ehlers, M.D., Ph.D., is joining the 2025 Fierce 15 honoree as chief scientific officer and head of R&D.
Whether it's looming tariff threats or the rise of China, you need a truly global view to navigate today's biopharma industry.
Hospitals that see improved long-term results in behavioral health patients will be those that prioritize metrics aligned with their care pathways. The post Rethinking How Hospitals Measure Behavioral Health Success appeared first on MedCity News .
Groundbreaking new therapies have exciting potential to treat and cure diseases while minimizing burden on patients; however, they create major clinical, operational and financial implications that must be planned for years in advance. The post Four Ways Health Systems Should Plan for the Next Wave of Breakthrough Therapies appeared first on MedCity News .
Roche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase in sales.
Assured Health raised $19 million for its AI agents that verify provider credentials and manage insurance enrollment for health systems and group practices. The startup said it can cut a process that usually takes months down to days. The post Assured Health Secures $19M to Get Providers In-Network Faster with Agentic AI appeared first on MedCity News .
Roche may have scrapped work on a T-cell engager being evaluated for lupus, but the company’s head of pharma told Fierce that still has a strategy for developing cell therapies for autoimmune diseases.
The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical and Medtronic.
GSK drug Jideytro received FDA approval for treating advanced cases of non-small cell lung cancer driven by ROS1 alterations. This molecule came from Nuvalent, which GSK recently acquired for $10.6 billion. The post $10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval appeared first on MedCity News .
Headspace announced partnerships with Charlie Health, Cortica, Prosper Health and Equip. The post Headspace Teams Up with 4 Companies for Specialty Care appeared first on MedCity News .
Andrew Aberdale will help expand AiM’s strategic partnership ecosystem, including its recent collaboration with Siemens Healthineers, the company said.